Benefits of prescribing low-dose digoxin in atrial fibrillation

CONCLUSION: Our findings are indicative of the favorable clinical outcomes that resulted from the addition of a low-dose of digoxin to the AF treatment regimen. However, larger studies/trials elucidating the outcomes of AF patients treated with the dual rate control therapy are required, to clarify the role of digoxin, guide the choice of agents, and standardize the AF treatment protocol.PMID:34724841 | PMC:PMC8573519 | DOI:10.1177/20587384211051955

Source: International Journal of Immunopathology and Pharmacology - November 2, 2021 Category: Allergy & Immunology Authors: Ciprian Ilie Rosca Nilima Rajpal Kundnani Anca Tudor Maria-Silvia Rosca Violeta-Ariana Nicoras Gabriela Otiman Elena Ciurariu Alin Ionescu Morariu Stelian Abhinav Sharma Claudia Borza Daniel Florin Lighezan Source Type: research